aluates Reports

$ 0.0

Automative

Global Companion Diagnostics (CDx) Development Services Market Research Report 2024

Published Date: April 2024

Report Code: QYRE-Auto-12A11016

Global Companion Diagnostics CDx Development Services Market Research Report 2022

BUY CHAPTERS

Global Companion Diagnostics (CDx) Development Services Market Research Report 2024

Code: QYRE-Auto-12A11016

Report

April 2024

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Geneuity Clinical Research Services

LabCorp

Quest Diagnostics

Q² Solutions

ResearchDx

Biocartis

Eurofins Scientific

Qiagen NV

BGI Genomics

Novogene

Interpace Biosciences

Almac Diagnostic Services

Cerba Research

MLM Medical Labs

MEDx Translational Medicine

Medical Biological Laboratories (MBL)

Companion Diagnostics (CDx) Development Services Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Companion Diagnostics (CDx) Development Services Market

The global Companion Diagnostics (CDx) Development Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Companion Diagnostics (CDx) Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Companion Diagnostics (CDx) Development Services.

Report Scope

The Companion Diagnostics (CDx) Development Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Companion Diagnostics (CDx) Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Companion Diagnostics (CDx) Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Companion Diagnostics (CDx) Development Services Market Report

Report Metric	Details
Report Name	Companion Diagnostics (CDx) Development Services Market
CAGR	5%
Segment by Type	Feasibility Studies Assay Development Analytical Validation Clinical Validation Others
Segment by Application	Infectious Diseases Neurological Disorders
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q² Solutions, ResearchDx, Almac Diagnostic Services, Biocartis, Cerba Research, Eurofins Scientific, MLM Medical Labs, Qiagen, BGI Genomics, MEDx Translational Medicine, Medical Biological Laboratories (MBL), Novogene
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Companion Diagnostics (CDx) Development Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Companion Diagnostics (CDx) Development Services Market report?

Ans: The main players in the Companion Diagnostics (CDx) Development Services Market are Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q² Solutions, ResearchDx, Almac Diagnostic Services, Biocartis, Cerba Research, Eurofins Scientific, MLM Medical Labs, Qiagen, BGI Genomics, MEDx Translational Medicine, Medical Biological Laboratories (MBL), Novogene

What are the Application segmentation covered in the Companion Diagnostics (CDx) Development Services Market report?

Ans: The Applications covered in the Companion Diagnostics (CDx) Development Services Market report are Infectious Diseases, Neurological Disorders

What are the Type segmentation covered in the Companion Diagnostics (CDx) Development Services Market report?

Ans: The Types covered in the Companion Diagnostics (CDx) Development Services Market report are Feasibility Studies, Assay Development, Analytical Validation, Clinical Validation, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Feasibility Studies

1.2.3 Assay Development

1.2.4 Analytical Validation

1.2.5 Clinical Validation

1.2.6 Others

1.3 Market by Application

1.3.1 Global Companion Diagnostics (CDx) Development Services Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Infectious Diseases

1.3.3 Neurological Disorders

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Companion Diagnostics (CDx) Development Services Market Perspective (2019-2030)

2.2 Companion Diagnostics (CDx) Development Services Growth Trends by Region

2.2.1 Global Companion Diagnostics (CDx) Development Services Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Companion Diagnostics (CDx) Development Services Historic Market Size by Region (2019-2024)

2.2.3 Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2025-2030)

2.3 Companion Diagnostics (CDx) Development Services Market Dynamics

2.3.1 Companion Diagnostics (CDx) Development Services Industry Trends

2.3.2 Companion Diagnostics (CDx) Development Services Market Drivers

2.3.3 Companion Diagnostics (CDx) Development Services Market Challenges

2.3.4 Companion Diagnostics (CDx) Development Services Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue

3.1.1 Global Top Companion Diagnostics (CDx) Development Services Players by Revenue (2019-2024)

3.1.2 Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Players (2019-2024)

3.2 Global Companion Diagnostics (CDx) Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Companion Diagnostics (CDx) Development Services Revenue

3.4 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio

3.4.1 Global Companion Diagnostics (CDx) Development Services Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Companion Diagnostics (CDx) Development Services Revenue in 2023

3.5 Companion Diagnostics (CDx) Development Services Key Players Head office and Area Served

3.6 Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service

3.7 Date of Enter into Companion Diagnostics (CDx) Development Services Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Companion Diagnostics (CDx) Development Services Breakdown Data by Type

4.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Type (2019-2024)

4.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2025-2030)

5 Companion Diagnostics (CDx) Development Services Breakdown Data by Application

5.1 Global Companion Diagnostics (CDx) Development Services Historic Market Size by Application (2019-2024)

5.2 Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Companion Diagnostics (CDx) Development Services Market Size (2019-2030)

6.2 North America Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)

6.4 North America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Companion Diagnostics (CDx) Development Services Market Size (2019-2030)

7.2 Europe Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)

7.4 Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size (2019-2030)

8.2 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2019-2024)

8.4 Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Companion Diagnostics (CDx) Development Services Market Size (2019-2030)

9.2 Latin America Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)

9.4 Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size (2019-2030)

10.2 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024)

10.4 Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Geneuity-Clinical Research Services

11.1.1 Geneuity-Clinical Research Services Company Detail

11.1.2 Geneuity-Clinical Research Services Business Overview

11.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Introduction

11.1.4 Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.1.5 Geneuity-Clinical Research Services Recent Development

11.2 Interpace Biosciences

11.2.1 Interpace Biosciences Company Detail

11.2.2 Interpace Biosciences Business Overview

11.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Introduction

11.2.4 Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.2.5 Interpace Biosciences Recent Development

11.3 Labcorp

11.3.1 Labcorp Company Detail

11.3.2 Labcorp Business Overview

11.3.3 Labcorp Companion Diagnostics (CDx) Development Services Introduction

11.3.4 Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.3.5 Labcorp Recent Development

11.4 Quest Diagnostics

11.4.1 Quest Diagnostics Company Detail

11.4.2 Quest Diagnostics Business Overview

11.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Introduction

11.4.4 Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.4.5 Quest Diagnostics Recent Development

11.5 Q² Solutions

11.5.1 Q² Solutions Company Detail

11.5.2 Q² Solutions Business Overview

11.5.3 Q² Solutions Companion Diagnostics (CDx) Development Services Introduction

11.5.4 Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.5.5 Q² Solutions Recent Development

11.6 ResearchDx

11.6.1 ResearchDx Company Detail

11.6.2 ResearchDx Business Overview

11.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Introduction

11.6.4 ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.6.5 ResearchDx Recent Development

11.7 Almac Diagnostic Services

11.7.1 Almac Diagnostic Services Company Detail

11.7.2 Almac Diagnostic Services Business Overview

11.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Introduction

11.7.4 Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.7.5 Almac Diagnostic Services Recent Development

11.8 Biocartis

11.8.1 Biocartis Company Detail

11.8.2 Biocartis Business Overview

11.8.3 Biocartis Companion Diagnostics (CDx) Development Services Introduction

11.8.4 Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.8.5 Biocartis Recent Development

11.9 Cerba Research

11.9.1 Cerba Research Company Detail

11.9.2 Cerba Research Business Overview

11.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Introduction

11.9.4 Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.9.5 Cerba Research Recent Development

11.10 Eurofins Scientific

11.10.1 Eurofins Scientific Company Detail

11.10.2 Eurofins Scientific Business Overview

11.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Introduction

11.10.4 Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.10.5 Eurofins Scientific Recent Development

11.11 MLM Medical Labs

11.11.1 MLM Medical Labs Company Detail

11.11.2 MLM Medical Labs Business Overview

11.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Introduction

11.11.4 MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.11.5 MLM Medical Labs Recent Development

11.12 Qiagen

11.12.1 Qiagen Company Detail

11.12.2 Qiagen Business Overview

11.12.3 Qiagen Companion Diagnostics (CDx) Development Services Introduction

11.12.4 Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.12.5 Qiagen Recent Development

11.13 BGI Genomics

11.13.1 BGI Genomics Company Detail

11.13.2 BGI Genomics Business Overview

11.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Introduction

11.13.4 BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.13.5 BGI Genomics Recent Development

11.14 MEDx Translational Medicine

11.14.1 MEDx Translational Medicine Company Detail

11.14.2 MEDx Translational Medicine Business Overview

11.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Introduction

11.14.4 MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.14.5 MEDx Translational Medicine Recent Development

11.15 Medical Biological Laboratories (MBL)

11.15.1 Medical Biological Laboratories (MBL) Company Detail

11.15.2 Medical Biological Laboratories (MBL) Business Overview

11.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Introduction

11.15.4 Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.15.5 Medical Biological Laboratories (MBL) Recent Development

11.16 Novogene

11.16.1 Novogene Company Detail

11.16.2 Novogene Business Overview

11.16.3 Novogene Companion Diagnostics (CDx) Development Services Introduction

11.16.4 Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024)

11.16.5 Novogene Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Geneuity Clinical Research Services

LabCorp

Quest Diagnostics

Q² Solutions

ResearchDx

Biocartis

Eurofins Scientific

Qiagen NV

BGI Genomics

Novogene

Interpace Biosciences

Almac Diagnostic Services

Cerba Research

MLM Medical Labs

MEDx Translational Medicine

Medical Biological Laboratories (MBL)

List of Tables

Table 1. Global Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Feasibility Studies

Table 3. Key Players of Assay Development

Table 4. Key Players of Analytical Validation

Table 5. Key Players of Clinical Validation

Table 6. Key Players of Others

Table 7. Global Companion Diagnostics (CDx) Development Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Companion Diagnostics (CDx) Development Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Companion Diagnostics (CDx) Development Services Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2019-2024)

Table 11. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Companion Diagnostics (CDx) Development Services Market Share by Region (2025-2030)

Table 13. Companion Diagnostics (CDx) Development Services Market Trends

Table 14. Companion Diagnostics (CDx) Development Services Market Drivers

Table 15. Companion Diagnostics (CDx) Development Services Market Challenges

Table 16. Companion Diagnostics (CDx) Development Services Market Restraints

Table 17. Global Companion Diagnostics (CDx) Development Services Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Companion Diagnostics (CDx) Development Services Market Share by Players (2019-2024)

Table 19. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2023)

Table 20. Ranking of Global Top Companion Diagnostics (CDx) Development Services Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Companion Diagnostics (CDx) Development Services Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Companion Diagnostics (CDx) Development Services Product Solution and Service

Table 24. Date of Enter into Companion Diagnostics (CDx) Development Services Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Companion Diagnostics (CDx) Development Services Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2019-2024)

Table 28. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Type (2025-2030)

Table 30. Global Companion Diagnostics (CDx) Development Services Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2019-2024)

Table 32. Global Companion Diagnostics (CDx) Development Services Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Companion Diagnostics (CDx) Development Services Revenue Market Share by Application (2025-2030)

Table 34. North America Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size by Country (2025-2030) & (US$ Million)

Table 49. Geneuity-Clinical Research Services Company Detail

Table 50. Geneuity-Clinical Research Services Business Overview

Table 51. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product

Table 52. Geneuity-Clinical Research Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 53. Geneuity-Clinical Research Services Recent Development

Table 54. Interpace Biosciences Company Detail

Table 55. Interpace Biosciences Business Overview

Table 56. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product

Table 57. Interpace Biosciences Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 58. Interpace Biosciences Recent Development

Table 59. Labcorp Company Detail

Table 60. Labcorp Business Overview

Table 61. Labcorp Companion Diagnostics (CDx) Development Services Product

Table 62. Labcorp Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 63. Labcorp Recent Development

Table 64. Quest Diagnostics Company Detail

Table 65. Quest Diagnostics Business Overview

Table 66. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product

Table 67. Quest Diagnostics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 68. Quest Diagnostics Recent Development

Table 69. Q² Solutions Company Detail

Table 70. Q² Solutions Business Overview

Table 71. Q² Solutions Companion Diagnostics (CDx) Development Services Product

Table 72. Q² Solutions Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 73. Q² Solutions Recent Development

Table 74. ResearchDx Company Detail

Table 75. ResearchDx Business Overview

Table 76. ResearchDx Companion Diagnostics (CDx) Development Services Product

Table 77. ResearchDx Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 78. ResearchDx Recent Development

Table 79. Almac Diagnostic Services Company Detail

Table 80. Almac Diagnostic Services Business Overview

Table 81. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product

Table 82. Almac Diagnostic Services Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 83. Almac Diagnostic Services Recent Development

Table 84. Biocartis Company Detail

Table 85. Biocartis Business Overview

Table 86. Biocartis Companion Diagnostics (CDx) Development Services Product

Table 87. Biocartis Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 88. Biocartis Recent Development

Table 89. Cerba Research Company Detail

Table 90. Cerba Research Business Overview

Table 91. Cerba Research Companion Diagnostics (CDx) Development Services Product

Table 92. Cerba Research Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 93. Cerba Research Recent Development

Table 94. Eurofins Scientific Company Detail

Table 95. Eurofins Scientific Business Overview

Table 96. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product

Table 97. Eurofins Scientific Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 98. Eurofins Scientific Recent Development

Table 99. MLM Medical Labs Company Detail

Table 100. MLM Medical Labs Business Overview

Table 101. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product

Table 102. MLM Medical Labs Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 103. MLM Medical Labs Recent Development

Table 104. Qiagen Company Detail

Table 105. Qiagen Business Overview

Table 106. Qiagen Companion Diagnostics (CDx) Development Services Product

Table 107. Qiagen Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 108. Qiagen Recent Development

Table 109. BGI Genomics Company Detail

Table 110. BGI Genomics Business Overview

Table 111. BGI Genomics Companion Diagnostics (CDx) Development Services Product

Table 112. BGI Genomics Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 113. BGI Genomics Recent Development

Table 114. MEDx Translational Medicine Company Detail

Table 115. MEDx Translational Medicine Business Overview

Table 116. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product

Table 117. MEDx Translational Medicine Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 118. MEDx Translational Medicine Recent Development

Table 119. Medical Biological Laboratories (MBL) Company Detail

Table 120. Medical Biological Laboratories (MBL) Business Overview

Table 121. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product

Table 122. Medical Biological Laboratories (MBL) Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 123. Medical Biological Laboratories (MBL) Recent Development

Table 124. Novogene Company Detail

Table 125. Novogene Business Overview

Table 126. Novogene Companion Diagnostics (CDx) Development Services Product

Table 127. Novogene Revenue in Companion Diagnostics (CDx) Development Services Business (2019-2024) & (US$ Million)

Table 128. Novogene Recent Development

Table 129. Research Programs/Design for This Report

Table 130. Key Data Information from Secondary Sources

Table 131. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Companion Diagnostics (CDx) Development Services Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Companion Diagnostics (CDx) Development Services Market Share by Type: 2023 VS 2030

Figure 3. Feasibility Studies Features

Figure 4. Assay Development Features

Figure 5. Analytical Validation Features

Figure 6. Clinical Validation Features

Figure 7. Others Features

Figure 8. Global Companion Diagnostics (CDx) Development Services Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Companion Diagnostics (CDx) Development Services Market Share by Application: 2023 VS 2030

Figure 10. Infectious Diseases Case Studies

Figure 11. Neurological Disorders Case Studies

Figure 12. Companion Diagnostics (CDx) Development Services Report Years Considered

Figure 13. Global Companion Diagnostics (CDx) Development Services Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Companion Diagnostics (CDx) Development Services Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Companion Diagnostics (CDx) Development Services Market Share by Region: 2023 VS 2030

Figure 16. Global Companion Diagnostics (CDx) Development Services Market Share by Players in 2023

Figure 17. Global Top Companion Diagnostics (CDx) Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Diagnostics (CDx) Development Services as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2023

Figure 19. North America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)

Figure 21. United States Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)

Figure 25. Germany Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Companion Diagnostics (CDx) Development Services Market Share by Region (2019-2030)

Figure 33. China Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)

Figure 41. Mexico Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Companion Diagnostics (CDx) Development Services Market Share by Country (2019-2030)

Figure 45. Turkey Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Geneuity-Clinical Research Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 48. Interpace Biosciences Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 49. Labcorp Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 50. Quest Diagnostics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 51. Q² Solutions Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 52. ResearchDx Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 53. Almac Diagnostic Services Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 54. Biocartis Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 55. Cerba Research Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 56. Eurofins Scientific Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 57. MLM Medical Labs Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 58. Qiagen Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 59. BGI Genomics Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 60. MEDx Translational Medicine Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 61. Medical Biological Laboratories (MBL) Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 62. Novogene Revenue Growth Rate in Companion Diagnostics (CDx) Development Services Business (2019-2024)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Pharmacogenomics Technology Theranostics Companion Diagnostics CDx Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Computer Aided Diagnostics CADx Market Research Report 2024

Global Preclinical Drug Development Services Market Research Report 2025

Global Cancer Diagnostics Service Market Research Report 2025

Clinical Laboratory Diagnostics Services Market

Radiological Diagnostics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Biopharmaceutical Development Support Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Clinical in Vitro Diagnostic Service Market Research Report 2024

Global Pill Testing Service Market Research Report 2025

Global At Home Diagnostic Testing Market Research Report 2025

Global Premium Diagnostic Radiology Monitors Market Research Report 2025

X Ray Acquisition and Diagnostic Software Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Diagnostic Radiology Display Market Research Report 2025

Global Biomedical Testing Services Market Research Report 2025

Global Precision Diagnostic Market Research Report 2024

Drug Analysis Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global In Vitro Diagnostics IVD Products and Test Market Research Report 2025

Global Drug Consulting Service Market Research Report 2025

Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-16G6108

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-27Q5892

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14K19926

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15N17310

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions